Finance

Lists
603367:SHA
Cisen Pharmaceutical Co Ltd
CN¥14,04
+0,57%
(+0,080) 1D
15 Okt., 10:30:35 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603367...
Open
CN¥13,85
High
CN¥14,12
Low
CN¥13,75
Mkt. cap
6,38 mjd
Avg. vol.
6,40 m
Volume
2,60 m
Dividend
2,68%
Quarterly dividend
CN¥0,09
Ex-dividend date
16 Sep. 2026
P/E ratio
13,92
52-wk high
CN¥24,85
52-wk low
CN¥12,13
EPS
CN¥1,01
Shares outstanding
453,35 m
No. of employees
3 k
Open
CN¥13,85
High
CN¥14,12
Low
CN¥13,75
Mkt. cap
6,38 mjd
Avg. vol.
6,40 m
Volume
2,60 m
Dividend
2,68%
Quarterly dividend
CN¥0,09
Ex-dividend date
16 Sep. 2026
P/E ratio
13,92
52-wk high
CN¥24,85
52-wk low
CN¥12,13
EPS
CN¥1,01
Shares outstanding
453,35 m
No. of employees
3 k
News stories
From web sources and news partners
About Cisen Pharmaceutical Co Ltd
CEO-
Employees3,11 k
Founded1970
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
844,01 m
860,94 m
850,35 m
842,81 m
Cost of goods sold
344,42 m
573,36 m
357,36 m
457,19 m
Cost of revenue
344,42 m
573,36 m
357,36 m
457,19 m
Research and development expenses
75,11 m
64,71 m
61,46 m
90,37 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
265,28 m
282,36 m
264,11 m
292,86 m
Operating expense
347,39 m
350,37 m
342,09 m
392,99 m
Total operating expenses
691,82 m
923,73 m
699,45 m
850,19 m
Operating income
152,19 m
-62,79 m
150,90 m
-7,38 m
Other non operating income
-2,09 m
2,84 m
-2,77 m
2,00 m
EBT including unusual items
166,86 m
72,88 m
143,85 m
141,45 m
EBT excluding unusual items
221,28 m
-25,12 m
183,29 m
60,69 m
Income tax expense
12,91 m
32,51 m
11,74 m
6,61 m
Effective tax rate
7,74%
44,60%
8,16%
4,67%
Other operating expenses
4,99 m
8,66 m
8,47 m
7,37 m
Net income
152,86 m
39,24 m
130,75 m
133,69 m
Net profit margin
18,11%
4,56%
15,38%
15,86%
Earnings per share
-
-
-
-
Interest and investment income
71,11 m
36,47 m
35,23 m
69,24 m
Interest expense
-
-847,99 k
-66,59 k
-110,35 k
Net interest expenses
71,11 m
35,62 m
35,16 m
69,13 m
Depreciation and amortization charges
-
-
-
-
EBITDA
206,30 m
-13,96 m
199,73 m
44,81 m
Gain or loss from assets sale
419,69 k
707,42 k
-
-10,76 k
AI content may include mistakes. Learn more
Google-programme